Interested in learning more about StopRA:National for your patients?
What is StopRA: National?
StopRA:National is a study being conducted by The Autoimmune Disease Prevention Center (ADPC) at the University of 麻豆传媒高清 designed to follow people who are at-risk of developing RA based on having a positive anti-CCP test, but without a diagnosis of RA.
The goal of StopRA:National is to create opportunities for anti-CCP+ individuals without clinical RA to participate in research to help us learn more about RA development, and ultimately how to prevent RA. Research indicates that anti-CCP+ individuals have a 30%-50% chance of developing RA. That is a high risk – but not 100%! As such, studying anti-CCP+ individuals is critical to learning more about RA development and prevention.
StopRA:National would like you to refer individuals who are anti-cyclic citrullinated positive (Anti-CCP+) without a clinical diagnosis of rheumatoid arthritis (RA) (i.e. they don’t have synovitis) who you would not otherwise treat with disease modifying therapy.
StopRA:National requires no travel or in-person visits for the participants and people from anywhere in the U.S. can participate! All study visits are completed remotely with the help of our research staff. Importantly, even blood draws will be completed locally (e.g. Quest or LabCorp) that will be coordinated by our research team.
StopRA:National’s ‘ask’ of you is to refer anti-CCP(+) people to our study; if they participate, we would also ask that as their rheumatologist you complete a short form periodically related to their joint exam and other relevant findings.
Key inclusion criteria:
- Positive for any clinically-used anti-CCP test (CCP2, CCP3). We also accept other anti-citrullinated protein tests such as anti-Sa. At this time, we are not enrolling people who are rheumatoid factor positive if they are anti-CCP negative.
- No history or current findings that they have active synovitis – and that you are not planning to use disease modifying therapy at this time.
- Age >=18 at the time of study enrollment (there is no upper age limit).
Of note – we highly value collaborations between the University of 麻豆传媒高清 and rheumatologists in the community. If your anti-CCP(+) patient is enrolled in our study, you will be considered a collaborator on the study with the possibility of being a co-author on any of our publications.